Fortress Biotech underperformed the market so far this year as of August 15, 2025.
1 report, 1 independent
Updated Aug 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Fortress Biotech underperformed the market so far this year as of August 15, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Coverage
Newest first; wire copies grouped- ZacksFortress Biotech (FBIO) Reports Q2 Loss, Beats Revenue Estimates Fortress Biotech (FBIO) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.31. This